Bioinformatic evaluation of L-arginine catabolic pathways in 24 cyanobacteria and transcriptional analysis of genes encoding enzymes of L-arginine catabolism in the cyanobacterium Synechocystis sp. PCC 6803
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2164
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Bioinformatic evaluation of L-arginine catabolic pathways in 24 cyanobacteria and transcriptional analysis of genes encoding enzymes of L-arginine catabolism in the cyanobacterium Synechocystis sp. PCC 6803 ; volume:8 ; number:1 ; day:28 ; month:11 ; year:2007 ; pages:1-28 ; date:12.2007
BMC genomics ; 8, Heft 1 (28.11.2007), 1-28, 12.2007
- Creator
-
Schriek, Sarah
- Contributor
-
Rückert, Christian
Staiger, Dorothee
Pistorius, Elfriede K.
Michel, Klaus-Peter
SpringerLink (Online service)
- DOI
-
10.1186/1471-2164-8-437
- URN
-
urn:nbn:de:1111-2016072729183
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Schriek, Sarah
- Rückert, Christian
- Staiger, Dorothee
- Pistorius, Elfriede K.
- Michel, Klaus-Peter
- SpringerLink (Online service)
Other Objects (12)
Transport of L-Arginine Related Cardiovascular Risk Markers
L-Arginine in diabetes: clinical and preclinical evidence
Controlled drug delivery of L-Arginine from a polymer matrix
Cleansing effect of acidic L-arginine on human oral biofilm
Purification and characterization of L-arginine deiminase from Penicillium chrysogenum
Controlled drug delivery of L-Arginine from a polymer matrix
Correction: L-Arginine in diabetes: clinical and preclinical evidence
L-Arginine supplementation as mitochondrial therapy in diabetic cardiomyopathy
Decreased systemic bioavailability of L-arginine in patients with cystic fibrosis
Reversal of cerebrovascular constriction in experimental cerebral malaria by L-arginine
Modification of substrate specificity of l-arginine oxidase for detection of l-citrulline
L-arginine Supplementation Ameliorates Chronic Bone Loss in Rheumatoid Arthritis
Transport of L-Arginine Related Cardiovascular Risk Markers
L-Arginine in diabetes: clinical and preclinical evidence
Controlled drug delivery of L-Arginine from a polymer matrix
Cleansing effect of acidic L-arginine on human oral biofilm
Purification and characterization of L-arginine deiminase from Penicillium chrysogenum
Controlled drug delivery of L-Arginine from a polymer matrix
Correction: L-Arginine in diabetes: clinical and preclinical evidence
L-Arginine supplementation as mitochondrial therapy in diabetic cardiomyopathy
Decreased systemic bioavailability of L-arginine in patients with cystic fibrosis
Reversal of cerebrovascular constriction in experimental cerebral malaria by L-arginine
Modification of substrate specificity of l-arginine oxidase for detection of l-citrulline
L-arginine Supplementation Ameliorates Chronic Bone Loss in Rheumatoid Arthritis
Transport of L-Arginine Related Cardiovascular Risk Markers
L-Arginine in diabetes: clinical and preclinical evidence
Controlled drug delivery of L-Arginine from a polymer matrix
Cleansing effect of acidic L-arginine on human oral biofilm
Purification and characterization of L-arginine deiminase from Penicillium chrysogenum
Controlled drug delivery of L-Arginine from a polymer matrix
Correction: L-Arginine in diabetes: clinical and preclinical evidence
L-Arginine supplementation as mitochondrial therapy in diabetic cardiomyopathy
Decreased systemic bioavailability of L-arginine in patients with cystic fibrosis
Reversal of cerebrovascular constriction in experimental cerebral malaria by L-arginine
Modification of substrate specificity of l-arginine oxidase for detection of l-citrulline